Safety/Effectiveness of Oral Chemokine Coreceptor 5 (CCR5) Antagonist INCB009471 in R5-tropic HIV Infected Patients

NCT00393120 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

45

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: INCB009471
DRUG: INCB009471
DRUG: Placebo comparator

Sponsor

Incyte Corporation